diapositiva 1 - sipps · 12 months, 21 (2.16%) reported cma but only 2 (0.210/0) were actually with...
TRANSCRIPT
![Page 1: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/1.jpg)
![Page 2: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/2.jpg)
![Page 3: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/3.jpg)
![Page 4: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/4.jpg)
![Page 5: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/5.jpg)
![Page 6: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/6.jpg)
1,9%
2,16%
2,22%
2,24%
4,9%
![Page 7: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/7.jpg)
![Page 8: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/8.jpg)
![Page 9: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/9.jpg)
![Page 10: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/10.jpg)
![Page 11: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/11.jpg)
![Page 12: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/12.jpg)
12
DIAGNOSTICA ALTERNATIVA
![Page 13: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/13.jpg)
![Page 14: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/14.jpg)
Allergy 2005
![Page 15: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/15.jpg)
![Page 16: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/16.jpg)
![Page 17: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/17.jpg)
![Page 18: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/18.jpg)
Kinesiologia - DRIA testSi ipotizza che un antigene al quale
il soggetto è allergico, se ingerito o messo in contatto con il corpo provochi una perdita di forza muscolare facilmente misurabile
Non è mai stato descritto alcun meccanismo allergico che coinvolga la muscolatura striata scheletrica.
![Page 19: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/19.jpg)
![Page 20: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/20.jpg)
+
![Page 21: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/21.jpg)
![Page 22: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/22.jpg)
22
![Page 23: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/23.jpg)
![Page 24: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/24.jpg)
![Page 25: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/25.jpg)
![Page 26: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/26.jpg)
![Page 27: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/27.jpg)
fascino persistente del mistero… o … promozione
non innocente del mistero,
in un mestiere, il nostro, che potrebbe ancora arricchirsi ricercando
la bellezza e la verità della geometria
Prof. Franco Panizon
![Page 28: Diapositiva 1 - SIPPS · 12 months, 21 (2.16%) reported CMA but only 2 (0.210/0) were actually with IgE-mediated CMA54 Epidemiology of Challenge-Confirmed CMA Pediatric Allergy Immunology](https://reader033.vdocuments.us/reader033/viewer/2022050117/5f4dedc715e22e4cc7156c5e/html5/thumbnails/28.jpg)